- Direction
- Stable
- Own history
- 70th
- Peers
- 50th
- Persistence
- TRANSIENT
· Pharmaceutical Preparations
RESEARCH SNAPSHOTElanco Animal Health Inc's latest supported as-filed period reports revenue of $1.4B. Every value below links to its SEC accession and metric lineage.
No material rule-based research observation currently meets GrossPattern's Insight value threshold. Current state, direction, and filing evidence remain available below.
Separate current dimensions—not a universal score or investment ranking.
A multidimensional view of the latest comparable filing—not a composite score or recommendation.
Level · gp.fundamentals.debt_to_revenue
Raw value 267.76% · OPTIONAL
Level · gp.fundamentals.capex_revenue_ratio
Raw value 2.41% · OPTIONAL
Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
Raw value 20.25% · OPTIONAL
Yoy · gp.fundamentals.revenue
Raw value 10.23% · CORE
Level · gp.fundamentals.inventory_revenue_ratio
Raw value 129.31% · OPTIONAL
Level · gp.fundamentals.gross_margin
Raw value 58.33% · CORE
Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
Business direction, financial quality, capital allocation, and governance evidence remain separate—never collapsed into a recommendation score.
Direction describes measurable company fundamentals. Governance reports observable evidence only; it does not grade management character or predict stock returns.
Latest available comparable states within 180 days, normalized with robust median/MAD statistics.
The most important deterministic changes, ranked by magnitude, issuer history, persistence, and accounting profile.
Current liabilities changed +33.0% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Working capital changed -12.5% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Each point keeps the date investors could first observe it and its accession.
ELAN · as filed with the SEC · reported-date aware
Direct SEC links, filing dates, report periods, and amendment flags.
0001916473-26-000046SEC ↗4Oct 20, 2026Period Oct 16, 20260001479079-26-000047SEC ↗4Oct 20, 2026Period Oct 16, 20260001724169-26-000047SEC ↗4Oct 19, 2026Period Oct 15, 20260001797894-26-000006SEC ↗4Oct 6, 2026Period Oct 2, 20260001916473-26-000044SEC ↗4Oct 6, 2026Period Oct 2, 20260001479079-26-000045SEC ↗4Oct 6, 2026Period Oct 2, 20260001724169-26-000045SEC ↗Transaction semantics distinguish purchases, sales, awards, exercises, withholding, and derivatives.
| Filed / transacted | Reporting owner | Semantics | Shares | Price | Notional | Source |
|---|---|---|---|---|---|---|
| Oct 16, 2026Filed Oct 20, 2026 | Modi Rajeev A.SEE REMARKS | Grant Or AwardDirect | 62.71 | $24 | $1,477 | Form 4 ↗ |
| Oct 15, 2026Filed Oct 19, 2026 | Bettington Timothy JSEE REMARKS | Open Market SaleDirect | 4,350 | $23 | $100,050 | Form 4 ↗ |
| Oct 2, 2026Filed Oct 6, 2026 | Modi Rajeev A.SEE REMARKS | Grant Or AwardDirect | 66.71 | $22 | $1,477 | Form 4 ↗ |
| Sep 30, 2026Filed Oct 1, 2026 | Anand Kapila KDirector | Grant Or AwardDirect | 642.03 | $22 | $14,375 | Form 4 ↗ |
| Sep 18, 2026 |
GrossPattern stores immutable raw artifacts, accession-scoped facts, parser and metric versions, dependency edges, quality state, and channel-specific publication rights. A restricted or unknown ancestor blocks the page and API automatically.
SEC source policy ↗Raw value 6.73% · OPTIONAL
Level · gp.fundamentals.sbc_revenue_ratio
Raw value 1.46% · OPTIONAL
Current ratio changed -21.0% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Free-cash-flow proxy changed +35.6% from the comparable as-filed period.
Operating cash flow changed +16.9% from the comparable as-filed period.
Capex / revenue changed -218 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Shares outstanding changed +0.6% from the comparable as-filed period. The change ranks at the 88th percentile of 8 prior comparable changes.
Method note “Materiality” here is an analytical magnitude band, not a legal conclusion. Full filing-text semantic changes remain unpublished while excerpt rights and review thresholds are unresolved.
Latest supported period in this snapshot: 2026-06-30. Duration facts use direct quarterly or annual SEC contexts; GrossPattern does not manufacture missing Q4 values.
0001679166-26-000013| Simmons Jeffrey NPRESIDENT, CEO AND DIRECTOR |
| Grant Or AwardDirect |
| 126.09 |
| $22 |
| $2,827 |
| Form 4 ↗ |
| Sep 18, 2026Filed Sep 22, 2026 | Modi Rajeev A.SEE REMARKS | Grant Or AwardDirect | 65.88 | $22 | $1,477 | Form 4 ↗ |
| Sep 4, 2026Filed Sep 9, 2026 | VanHimbergen Robert MEVP and CFO | Grant Or AwardDirect | 8.04 | $25 | $197 | Form 4 ↗ |
| Sep 4, 2026Filed Sep 9, 2026 | Modi Rajeev A.SEE REMARKS | Grant Or AwardDirect | 60.28 | $25 | $1,477 | Form 4 ↗ |
| Aug 21, 2026Filed Aug 25, 2026 | Modi Rajeev A.SEE REMARKS | Grant Or AwardDirect | 61.62 | $24 | $1,477 | Form 4 ↗ |
| Aug 21, 2026Filed Aug 25, 2026 | VanHimbergen Robert MEVP and CFO | Grant Or AwardDirect | 8.22 | $24 | $197 | Form 4 ↗ |
| Aug 21, 2026Filed Aug 25, 2026 | Simmons Jeffrey NPRESIDENT, CEO AND DIRECTOR | Grant Or AwardDirect | 117.94 | $24 | $2,827 | Form 4 ↗ |
| Aug 20, 2026Filed Aug 21, 2026 | Kurzius Lawrence ErikDirector | Open Market PurchaseDirect | 40,000 | $23 | $935,920 | Form 4 ↗ |
| Aug 18, 2026Filed Aug 18, 2026 | O'Neill ShivGC AND CORP SEC | Open Market PurchaseDirect | 3,998 | $24 | $94,273 | Form 4 ↗ |
| Aug 12, 2026Filed Aug 13, 2026 | Harrington Michael JDirector | Open Market PurchaseDirect | 5,000 | $22 | $109,100 | Form 4 ↗ |
| Aug 7, 2026Filed Aug 10, 2026 | VanHimbergen Robert MEVP and CFO | Grant Or AwardDirect | 8.91 | $22 | $197 | Form 4 ↗ |
| Aug 7, 2026Filed Aug 10, 2026 | Simmons Jeffrey NPRESIDENT, CEO AND DIRECTOR | Grant Or AwardDirect | 127.8 | $22 | $2,827 | Form 4 ↗ |
| Aug 7, 2026Filed Aug 10, 2026 | VanHimbergen Robert MEVP and CFO | Open Market PurchaseDirect | 4,200 | $23 | $96,926 | Form 4 ↗ |
| Aug 7, 2026Filed Aug 10, 2026 | Herendeen PaulDirector | Open Market PurchaseDirect | 10,000 | $24 | $236,850 | Form 4 ↗ |
| Aug 7, 2026Filed Aug 10, 2026 | Modi Rajeev A.SEE REMARKS | Grant Or AwardDirect | 66.77 | $22 | $1,477 | Form 4 ↗ |
| Jul 24, 2026Filed Jul 28, 2026 | Simmons Jeffrey NPRESIDENT, CEO AND DIRECTOR | Grant Or AwardDirect | 113.49 | $25 | $2,827 | Form 4 ↗ |